{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Cevimeline Hydrochloride is a prescription oral capsule medication containing 30 mg of the active ingredient, used as a cholinergic muscarinic agonist to stimulate certain receptors. Manufactured by Hikma Pharmaceuticals USA Inc. and distributed by Bryant Ranch Prepack, it's available in bottles of 30, 60, or 90 capsules. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Cevimeline hydrochloride \u2014 ANDA 020989 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020989", "mediaType": "text/html", "title": "Cevimeline hydrochloride"}], "identifier": "ANDA020989", "issued": "2016-09-16", "keyword": ["drug-safety", "fda", "health-care", "medications", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Cevimeline hydrochloride"}